Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity

Sebastien Farnaud, Claire Spiller, Laura C. Moriarty, Alpesh Patel, Vanya Gant, Edward W. Odell, Robert W. Evans

Research output: Contribution to journalArticle

66 Citations (Scopus)

Abstract

Synthetic peptides derived from human and bovine lactoferricin, as well as tritrpticin sequences, were assayed for antimicrobial activity against wild-type Escherichia coli and LPS mutant strains. Antimicrobial activity was only obtained with peptides derived from the bovine lactoferricin sequence and peptides corresponding to chimeras of human and bovine sequences. None of the peptides corresponding to different regions of native human lactoferricin showed any antimicrobial activity. The results underline the importance of the content of tryptophan and arginine residues, and the relative location of these residues for antimicrobial activity. Results obtained for the same assays performed with LPS mutants suggest that lipid A is not the main binding site for lactoferricin which interacts first with the negative charges present in the inner core. Computer modelling of the most active peptides led to a model in which positively charged residues of the cationic peptide interact with negative charges carried by the LPS to disorganise the structure of the outer membrane and facilitate the approach of tryptophan residues to the lipid A in order to promote hydrophobic interactions.

Original languageEnglish
Pages (from-to)193-199
Number of pages7
JournalFEMS Microbiology Letters
Volume233
Issue number2
DOIs
Publication statusPublished - 1 Apr 2004
Externally publishedYes

Fingerprint

Peptides
Lipid A
Tryptophan
Hydrophobic and Hydrophilic Interactions
Population Groups
Arginine
lactoferricin B
Binding Sites
Escherichia coli
Membranes

Keywords

  • Cationic antimicrobial peptides
  • Lactoferricin
  • Lactoferrin
  • LPS
  • MBC

ASJC Scopus subject areas

  • Microbiology
  • Molecular Biology
  • Genetics

Cite this

Farnaud, S., Spiller, C., Moriarty, L. C., Patel, A., Gant, V., Odell, E. W., & Evans, R. W. (2004). Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity. FEMS Microbiology Letters, 233(2), 193-199. https://doi.org/10.1016/j.femsle.2004.01.039

Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity. / Farnaud, Sebastien; Spiller, Claire; Moriarty, Laura C.; Patel, Alpesh; Gant, Vanya; Odell, Edward W.; Evans, Robert W.

In: FEMS Microbiology Letters, Vol. 233, No. 2, 01.04.2004, p. 193-199.

Research output: Contribution to journalArticle

Farnaud, S, Spiller, C, Moriarty, LC, Patel, A, Gant, V, Odell, EW & Evans, RW 2004, 'Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity' FEMS Microbiology Letters, vol. 233, no. 2, pp. 193-199. https://doi.org/10.1016/j.femsle.2004.01.039
Farnaud, Sebastien ; Spiller, Claire ; Moriarty, Laura C. ; Patel, Alpesh ; Gant, Vanya ; Odell, Edward W. ; Evans, Robert W. / Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity. In: FEMS Microbiology Letters. 2004 ; Vol. 233, No. 2. pp. 193-199.
@article{1f931bbebdbc42898fc8bc78acd1cb4c,
title = "Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity",
abstract = "Synthetic peptides derived from human and bovine lactoferricin, as well as tritrpticin sequences, were assayed for antimicrobial activity against wild-type Escherichia coli and LPS mutant strains. Antimicrobial activity was only obtained with peptides derived from the bovine lactoferricin sequence and peptides corresponding to chimeras of human and bovine sequences. None of the peptides corresponding to different regions of native human lactoferricin showed any antimicrobial activity. The results underline the importance of the content of tryptophan and arginine residues, and the relative location of these residues for antimicrobial activity. Results obtained for the same assays performed with LPS mutants suggest that lipid A is not the main binding site for lactoferricin which interacts first with the negative charges present in the inner core. Computer modelling of the most active peptides led to a model in which positively charged residues of the cationic peptide interact with negative charges carried by the LPS to disorganise the structure of the outer membrane and facilitate the approach of tryptophan residues to the lipid A in order to promote hydrophobic interactions.",
keywords = "Cationic antimicrobial peptides, Lactoferricin, Lactoferrin, LPS, MBC",
author = "Sebastien Farnaud and Claire Spiller and Moriarty, {Laura C.} and Alpesh Patel and Vanya Gant and Odell, {Edward W.} and Evans, {Robert W.}",
year = "2004",
month = "4",
day = "1",
doi = "10.1016/j.femsle.2004.01.039",
language = "English",
volume = "233",
pages = "193--199",
journal = "FEMS Microbiology Letters",
issn = "0378-1097",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Interactions of lactoferricin-derived peptides with LPS and antimicrobial activity

AU - Farnaud, Sebastien

AU - Spiller, Claire

AU - Moriarty, Laura C.

AU - Patel, Alpesh

AU - Gant, Vanya

AU - Odell, Edward W.

AU - Evans, Robert W.

PY - 2004/4/1

Y1 - 2004/4/1

N2 - Synthetic peptides derived from human and bovine lactoferricin, as well as tritrpticin sequences, were assayed for antimicrobial activity against wild-type Escherichia coli and LPS mutant strains. Antimicrobial activity was only obtained with peptides derived from the bovine lactoferricin sequence and peptides corresponding to chimeras of human and bovine sequences. None of the peptides corresponding to different regions of native human lactoferricin showed any antimicrobial activity. The results underline the importance of the content of tryptophan and arginine residues, and the relative location of these residues for antimicrobial activity. Results obtained for the same assays performed with LPS mutants suggest that lipid A is not the main binding site for lactoferricin which interacts first with the negative charges present in the inner core. Computer modelling of the most active peptides led to a model in which positively charged residues of the cationic peptide interact with negative charges carried by the LPS to disorganise the structure of the outer membrane and facilitate the approach of tryptophan residues to the lipid A in order to promote hydrophobic interactions.

AB - Synthetic peptides derived from human and bovine lactoferricin, as well as tritrpticin sequences, were assayed for antimicrobial activity against wild-type Escherichia coli and LPS mutant strains. Antimicrobial activity was only obtained with peptides derived from the bovine lactoferricin sequence and peptides corresponding to chimeras of human and bovine sequences. None of the peptides corresponding to different regions of native human lactoferricin showed any antimicrobial activity. The results underline the importance of the content of tryptophan and arginine residues, and the relative location of these residues for antimicrobial activity. Results obtained for the same assays performed with LPS mutants suggest that lipid A is not the main binding site for lactoferricin which interacts first with the negative charges present in the inner core. Computer modelling of the most active peptides led to a model in which positively charged residues of the cationic peptide interact with negative charges carried by the LPS to disorganise the structure of the outer membrane and facilitate the approach of tryptophan residues to the lipid A in order to promote hydrophobic interactions.

KW - Cationic antimicrobial peptides

KW - Lactoferricin

KW - Lactoferrin

KW - LPS

KW - MBC

UR - http://www.scopus.com/inward/record.url?scp=1842582719&partnerID=8YFLogxK

U2 - 10.1016/j.femsle.2004.01.039

DO - 10.1016/j.femsle.2004.01.039

M3 - Article

VL - 233

SP - 193

EP - 199

JO - FEMS Microbiology Letters

JF - FEMS Microbiology Letters

SN - 0378-1097

IS - 2

ER -